Bicalutamide is an active pharmaceutical ingredient used primarily as an antiandrogen in the manufacturing of therapies for prostate cancer. It is typically employed in combination with gonadotropin-releasing hormone analogues or surgical castration for metastatic disease, and as a high-dose monotherapy for locally advanced prostate cancer.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 90357-06-5
Pitolisant hydrochloride
pharmaceutical raw material
Urokinase
pharmaceutical raw material
Angiotensin I
pharmaceutical raw material
Bleomycin sulfate
pharmaceutical raw material
N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide
LKJPYSCBVHEWIU-UHFFFAOYSA-N
CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O